Bladder cancer symptoms most often begin with blood in the urine, a sign that is usually painless and easy to overlook. Blood may be visible, turning urine pink, red, or cola-colored, or it may be microscopic and found only on a lab test. Because many harmless conditions also cause blood in the urine, the goal of this guide is to explain the warning signs calmly and clearly, without alarm. In this article you will learn what bladder cancer is, the main bladder cancer symptoms and warning signs, the leading causes and risk factors, how doctors diagnose it using urine and blood tests, how it is staged and graded, the main treatment options, and when to see a doctor.
What is bladder cancer?
Bladder cancer occurs when cells in the bladder grow without control. The bladder is a hollow, muscular organ in the lower abdomen that stores urine made by the kidneys, according to the National Cancer Institute. Most tumors begin in the urothelial cells that line the inside of the bladder.
Almost all bladder cancers are urothelial carcinoma, which was previously called transitional cell carcinoma. Urothelial cells are sometimes called transitional cells because they stretch when the bladder fills and shrink when it empties. Rarer types include squamous cell carcinoma, adenocarcinoma, and small cell carcinoma. Doctors also describe the disease by how deep it has grown: non-muscle-invasive bladder cancer has not reached the muscle wall, while muscle-invasive bladder cancer has spread into or beyond it. Most cases are non-muscle-invasive when first found and are often highly treatable, the National Cancer Institute notes.
Bladder cancer symptoms and warning signs
The most common bladder cancer symptoms involve the urine and the way you pass it. Blood in the urine is the warning sign people notice first; it is often painless, may come and go, and can appear even when you otherwise feel well. Searches for the “5 warning signs of bladder cancer” usually point to the same short list that major institutions describe.
According to Mayo Clinic and MedlinePlus, the signs and symptoms to know are:
- Blood in the urine (hematuria), which may look bright red or cola-colored, or be invisible and detected only on a lab test
- A frequent or urgent need to urinate
- Pain or burning during urination
- Passing urine often in small amounts, or feeling the bladder has not emptied
- Low back or pelvic pain, which is more often linked to advanced disease
These symptoms overlap heavily with far more common conditions, such as urinary tract infections, kidney stones, and an enlarged prostate. A single episode does not mean cancer. Still, visible blood in the urine should always be evaluated, even when it happens only once and is not painful. If you want to understand what bleeding looks like and why it happens, our guide explains the causes and patterns of verta virtsassa. The same urinary changes can also accompany a urinary tract infection, which is why testing matters before drawing conclusions.
Syyt ja riskitekijät
Bladder cancer develops when cells in the bladder lining acquire DNA changes that let them multiply and survive abnormally, Mayo Clinic explains. Several factors raise the risk, though having one does not mean a person will develop the disease.
Smoking is the leading risk factor
Smoking is the single biggest risk factor for bladder cancer. As the body processes the chemicals in tobacco smoke, some are excreted in the urine, where they can damage the bladder lining over time. Mayo Clinic reports that smokers are about three times more likely to develop bladder cancer than non-smokers, and quitting lowers the risk.
Other established risk factors
- Older age, with most diagnoses occurring after age 55
- Being male, as men develop bladder cancer more often than women
- Workplace exposure to certain chemicals, including those used in dye, rubber, leather, textile, and paint manufacturing, as well as arsenic
- Previous cancer treatment, such as the drug cyclophosphamide or pelvic radiation
- Long-term bladder irritation or chronic infection, including from prolonged catheter use
- A personal or family history of bladder cancer, and rarely an inherited condition such as Lynch syndrome
Because some urinary symptoms in men relate to the prostate rather than the bladder, it can help to understand how the two differ; our overview covers eturauhassyöpä in plain language.
How bladder cancer is diagnosed
No single test confirms bladder cancer on its own. Doctors combine a medical history, a physical exam, urine and blood tests, direct visualization, and imaging. Urine tests are often the first step, which is where reading your results carefully becomes useful.
Urinalysis and urine cytology
A urinalysis checks a urine sample for blood, infection, and other clues. Microscopic blood can be an early signal that prompts further testing. To see how each line on the report is read, our explainer walks through a urinalysis report. Because infection and inflammation can also raise white cells in the sample, it helps to understand what leukocytes in urine mean before assuming the worst.
Urine cytology examines cells shed into the urine under a microscope to look for abnormal or cancerous cells. It is good at detecting high-grade tumors but can miss low-grade ones, so it is used alongside other tests rather than alone. Our guide explains how to read a urine cytology report.
Urine tumor marker tests
Urine tumor marker tests look for substances made by bladder cancer cells or produced in response to them, the National Cancer Institute explains. Examples include NMP22 and UroVysion FISH, which detects chromosomal changes. These support detection and surveillance but are generally adjuncts, not replacements for direct examination. For background, our article covers how doctors use kasvainmarkkerit, and a related explainer reviews the CEA blood marker.
Cystoscopy and imaging
Cystoscopy is the diagnostic standard. A urologist passes a thin, lighted tube through the urethra to view the bladder lining directly and, if needed, take a tissue sample; a biopsy examined by a pathologist is what confirms cancer. Imaging such as a CT urogram or intravenous pyelogram shows the kidneys, ureters, and bladder and helps assess the extent of disease. The National Cancer Institute describes these tests used to diagnose bladder cancer in detail.
Where blood tests fit
Blood tests do not diagnose bladder cancer, but they add context. A complete blood count can flag anemia, which sometimes accompanies ongoing blood loss in the urine; our guide explains the täydellinen verenkuva. To put any abnormal value in perspective, it helps to know how to lue verikokeiden tulokset as a whole rather than one number at a time.
| Testata | What it examines | What it can show |
|---|---|---|
| Virtsa-analyysi | A urine sample by dipstick and microscope | Visible or microscopic blood, signs of infection, other clues |
| Virtsan sytologia | Cells shed into the urine under a microscope | Abnormal or cancerous cells; better for high-grade tumors |
| Urine tumor markers | Substances or genetic changes in a urine sample | Support for detection or surveillance, usually as an adjunct |
| Cystoscopy with biopsy | The bladder lining viewed directly, with a tissue sample | Confirms cancer and guides grading and staging |
| CT urogram or IVP | The kidneys, ureters, and bladder using contrast dye | Tumor location and the extent of disease |
| Täydellinen verenkuva | Red cells, white cells, and platelets in the blood | Anemia that may accompany blood loss in the urine |
Staging and grading basics
If a biopsy confirms cancer, doctors describe it in two ways. Grade reflects how abnormal the cells look and how quickly they may grow, with low-grade tumors tending to grow slowly and high-grade tumors being more aggressive. Stage describes how far the cancer has spread, from tumors confined to the bladder lining through to those reaching the muscle wall, nearby tissue, lymph nodes, or distant organs.
The broad split between non-muscle-invasive and muscle-invasive disease strongly shapes the plan. Knowing the stage and grade is essential for choosing treatment, the National Cancer Institute notes, and these details come from the pathology report and imaging rather than from symptoms.
Hoitovaihtoehdot
Treatment depends on the type, stage, and grade of the cancer, along with overall health and personal preferences. The aim here is to outline the main approaches, not to predict outcomes. According to Mayo Clinic and MedlinePlus, the main options include the following.
- Transurethral resection of bladder tumor (TURBT), a procedure to remove tumors through the urethra, often used for non-muscle-invasive disease and to obtain tissue
- Intravesical therapy, in which medicine is placed directly into the bladder; this includes BCG, an immunotherapy that prompts an immune response against cancer cells
- Chemotherapy, which may be given into the bladder or throughout the body
- Immunotherapy with checkpoint inhibitors, which help the immune system recognize and attack cancer cells
- Radiation therapy, which uses high-energy beams to target cancer cells
- Surgery to remove part or all of the bladder (cystectomy) in more advanced cases
Because early-stage bladder cancer can return after treatment, follow-up testing for years afterward is common, Mayo Clinic explains. That surveillance is one reason urine-based tests have attracted so much research attention.
Uusimmat tieteelliset edistysaskeleet
The points below summarize recent peer-reviewed work and active clinical trials, based on articles retrieved from PubMed, results from Consensus, and listings from ClinicalTrials.gov. This is general information, not medical advice, and each finding should be read in context.
Much recent research focuses on non-invasive urine tests that could reduce how often patients need cystoscopy. A 2024 systematic review of urine-based biomarker assays available in the United States, including NMP22, UroVysion, CxBladder, and Bladder EpiCheck, found that while these tests may add value, none has yet shown enough evidence to replace cystoscopy as the diagnostic standard (Bladder Cancer, 2024; DOI-koodi). An earlier systematic review of eleven urinary biomarkers agreed: most detect cancer more sensitively than cytology but are less specific, making them complementary to cystoscopy rather than a substitute (World J Urol, 2023; DOI-koodi). In short, urine molecular tests are promising adjuncts, but a negative result does not rule out disease.
This active field is reflected in current trials. As of mid-2026, ClinicalTrials.gov listed more than two dozen recruiting studies pairing bladder cancer with urine testing, including a randomized trial comparing urine tests with cystoscopy for surveillance using the Bladder EpiCheck and Xpert Bladder Cancer Monitor assays (NCT05796375), and observational studies of the CxBladder test for detecting recurrence (NCT05080998). These studies are ongoing, and their results are not yet established practice.
Treatment has also advanced. A large phase 3 randomized trial of 886 patients with previously untreated advanced urothelial cancer found that the combination of enfortumab vedotin, an antibody-drug conjugate, with the immunotherapy pembrolizumab improved median overall survival to 31.5 months, compared with 16.1 months for standard chemotherapy (N Engl J Med, 2024; DOI-koodi). For earlier-stage disease, intravesical BCG remains a mainstay, while checkpoint inhibitors and antibody-drug conjugates continue to expand the options, as summarized by the National Cancer Institute in its overview of advances in bladder cancer research. These are advances for specific groups of patients and are applied case by case.
Sanasto
| Termi | Määritelmä |
|---|---|
| Hematuria | Blood in the urine, which may be visible or only found on a lab test |
| Urothelial carcinoma | The most common type of bladder cancer, which begins in the bladder lining; once called transitional cell carcinoma |
| Non-muscle-invasive | Cancer that has not grown into the muscle wall of the bladder |
| Muscle-invasive | Cancer that has spread into or beyond the bladder muscle wall |
| Cystoscopy | A procedure using a thin camera to look inside the bladder |
| Virtsan sytologia | A test that examines cells in the urine for abnormal or cancerous changes |
| TURBT | Transurethral resection of bladder tumor, a procedure that removes tumors through the urethra |
| BCG | An intravesical immunotherapy placed into the bladder to prompt an immune response against cancer cells |
| Grade | How abnormal cancer cells look and how quickly they may grow |
| Vaihe | How far a cancer has spread within and beyond the bladder |
Usein kysytyt kysymykset
What causes bladder cancer?
Bladder cancer develops when cells in the bladder lining acquire DNA changes that let them multiply abnormally. The leading risk factor is smoking, because harmful chemicals from tobacco are excreted in the urine and can damage the bladder over time. Other contributors include older age, being male, workplace chemical exposure, previous pelvic radiation, and chronic bladder irritation. Having a risk factor does not mean a person will develop the disease.
What are the warning signs of bladder cancer?
The main warning sign is blood in the urine, which is often painless and may come and go. It can be visible, turning urine pink or cola-colored, or microscopic and found only on a urinalysis. Other signs include urinating frequently or urgently, pain or burning when urinating, and passing only small amounts at a time. These overlap with common conditions such as infections and stones, but visible blood always deserves evaluation, even if it happens once.
Is bladder cancer curable or treatable?
Bladder cancer is treatable, and most cases are found at an early, non-muscle-invasive stage when treatment options are most effective, according to Mayo Clinic. Treatments include procedures to remove tumors, medicine placed into the bladder, chemotherapy, immunotherapy, radiation, and surgery. Outcomes depend on the type, grade, and stage, as well as individual health, so only a treating team can discuss what to expect for a specific person. Because early-stage disease can return, ongoing follow-up is an important part of care.
Does bladder cancer show up in blood or urine tests?
Urine tests are central to detection. A urinalysis can reveal visible or microscopic blood, urine cytology can find abnormal cells, and urine tumor marker tests can support detection and surveillance. However, none of these confirms cancer on its own; cystoscopy with a biopsy is what provides a diagnosis. Blood tests do not diagnose bladder cancer, but a complete blood count may show anemia linked to blood loss.
Is bladder cancer hereditary?
Most bladder cancer is not inherited and relates instead to factors such as smoking, age, and chemical exposure. A family history can modestly raise risk, and rarely an inherited condition called Lynch syndrome increases the chance of cancers in the urinary tract and elsewhere, Mayo Clinic notes. If close relatives have had bladder or related cancers, it is reasonable to mention this to a clinician, who can discuss whether any extra attention is warranted.
Milloin minun pitäisi mennä lääkäriin?
See a doctor if you notice blood in your urine, even once and even without pain, or if you have ongoing urinary changes such as frequency, urgency, or burning that do not settle. Seek prompt care for heavy bleeding, clots, an inability to urinate, fever with urinary symptoms, or severe back or side pain. These signs do not necessarily mean cancer, but they should be checked so the cause can be identified and treated.
Lähteet
- What Is Bladder Cancer? (National Cancer Institute)
- Bladder cancer: Symptoms and causes (Mayo Clinic)
- Bladder Cancer (MedlinePlus, National Library of Medicine)
- Heard JR, Mitra AP. Noninvasive Tests for Bladder Cancer Detection and Surveillance: A Systematic Review of Commercially Available Assays. Bladder Cancer. 2024. DOI-koodi
- Soorojebally Y, et al. Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review. World J Urol. 2023. DOI-koodi
- Powles T, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med. 2024. DOI-koodi
- Advances in Bladder Cancer Research (National Cancer Institute)
The research summaries above are based on articles retrieved from PubMed, Consensus, and ClinicalTrials.gov.
Lisälukemista
- Hematuria (veri virtsassa): syyt ja oireet
- Virtsasytologia: tulosten ymmärtäminen ja diagnoosi
- Virtsanäytteen tulokset: tulkintaopas
- Kasvainmarkkerit: merkitys, käyttö ja rajoitukset
- Täydellinen verenkuva: lue tuloksesi
Ymmärrä laboratoriotuloksiasi tekoälyn DiagMen avulla
Tulkitse tuloksesi muutamassa minuutissa
Bladder cancer symptoms often surface first in everyday tests, yet a urinalysis, a urine cytology report, a complete blood count, or a tumor marker result can be hard to read on your own. AI DiagMe turns those values into clear, plain-language context so you can prepare focused questions for your clinician. It is built to help you understand your results, not to diagnose you, and it does not replace a doctor.
